Co-design of Guidance for Patient and Public Involvement in Psychedelic Research

被引:10
作者
Close, James B. [1 ]
Bornemann, Julia [1 ]
Piggin, Maria [2 ]
Jayacodi, Sandra [3 ]
Luan, Lisa Xiaolu [1 ]
Carhart-Harris, Robin [1 ]
Spriggs, Meg Jo [1 ]
机构
[1] Imperial Coll London, Ctr Psychedel Res, Div Brain Sci, London, England
[2] Imperial Coll London, Patient Experience Res Ctr, London, England
[3] Imperial Biomed Res Ctr Publ Panel, London, England
关键词
psychedelics; research; patient; public; involvement; PPI; guideline; strategy; LIFE-THREATENING CANCER; PSILOCYBIN TREATMENT; ANXIETY; DEPRESSION; HEALTH; PSYCHOTHERAPY; CHALLENGES;
D O I
10.3389/fpsyt.2021.727496
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Within the context of scientific research, patient and public involvement (PPI) is defined as research performed "with" or "by" patients and members of the public, rather than "to," "about", or "for" them. When carried out systematically and thoughtfully, PPI has the potential to strengthen the quality and impact of research by fostering accountability, transparency, and relevance. There exist numerous guidelines, frameworks and tools for supporting PPI, however, these do not account for the unique challenges faced in psychedelic research. This paper describes the co-design of guidance intended to help build, evaluate and improve PPI in psychedelic research. A steering group was formed to design and run a co-design workshop alongside public collaborators. Insights from this workshop were analyzed and refined into a comprehensive and readily usable guide for planning PPI specific to the field of psychedelic research. Core values emerging from the process focused on the essential importance of trust, learning, purpose and inclusivity. It is hoped that this guidance will be a starting point for incorporating PPI in future psychedelic research, so that it can grow and adapt as this burgeoning field of research progresses.
引用
收藏
页数:10
相关论文
共 77 条
[1]   Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer [J].
Agin-Liebes, Gabrielle, I ;
Malone, Tara ;
Yalch, Matthew M. ;
Mennenga, Sarah E. ;
Ponte, K. Linnae ;
Guss, Jeffrey ;
Bossis, Anthony P. ;
Grigsby, Jim ;
Fischer, Stacy ;
Ross, Stephen .
JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (02) :155-166
[2]   Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies [J].
Andersen, Kristoffer A. A. ;
Carhart-Harris, Robin ;
Nutt, David J. ;
Erritzoe, David .
ACTA PSYCHIATRICA SCANDINAVICA, 2021, 143 (02) :101-118
[3]  
[Anonymous], 1980, LSD psychotherapy
[4]  
[Anonymous], 2012, BRIEFING NOTES RES P
[5]  
[Anonymous], 2020, CENSUS QUALITY INDIC
[6]   A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress [J].
Bagley H.J. ;
Short H. ;
Harman N.L. ;
Hickey H.R. ;
Gamble C.L. ;
Woolfall K. ;
Young B. ;
Williamson P.R. .
Research Involvement and Engagement, 2 (1)
[7]   Inside co-production: Ruling, resistance, and practice [J].
Bevir, Mark ;
Needham, Catherine ;
Waring, Justin .
SOCIAL POLICY & ADMINISTRATION, 2019, 53 (02) :197-202
[8]   Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study [J].
Bogenschutz, Michael P. ;
Forcehimes, Alyssa A. ;
Pommy, Jessica A. ;
Wilcox, Claire E. ;
Barbosa, P. C. R. ;
Strassman, Rick J. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (03) :289-299
[9]   Mapping the impact of patient and public involvement on health and social care research: a systematic review [J].
Brett, Jo ;
Staniszewska, Sophie ;
Mockford, Carole ;
Herron-Marx, Sandra ;
Hughes, John ;
Tysall, Colin ;
Suleman, Rashida .
HEALTH EXPECTATIONS, 2014, 17 (05) :637-650
[10]   Psilocybin with psychological support for treatment-resistant depression: six-month follow-up [J].
Carhart-Harris, R. L. ;
Bolstridge, M. ;
Day, C. M. J. ;
Rucker, J. ;
Watts, R. ;
Erritzoe, D. E. ;
Kaelen, M. ;
Giribaldi, B. ;
Bloomfield, M. ;
Pilling, S. ;
Rickard, J. A. ;
Forbes, B. ;
Feilding, A. ;
Taylor, D. ;
Curran, H. V. ;
Nutt, D. J. .
PSYCHOPHARMACOLOGY, 2018, 235 (02) :399-408